Biomarker data from CE-IVD tests play an essential role in clinical trials, but generating reliable results requires fit-for-purpose assay optimization and a clear context of use.
This can pose a challenge when scientific and regulatory responsibilities are divided between CROs and diagnostic labs.
This poster highlights how Svar's CRO and Wieslab Diagnostic Laboratory work in close collaboration, delivering an integrated approach to streamline fit-for-purpose optimizations and deliver clinically meaningful biomarker data.
Download the poster to explore how strategic assay optimization transforms CE-IVD tests into reliable, study-ready biomarker tools.
